Figure 1. Western blot analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human Hela whole cell lysates,
Lane 2: human HEK293 whole cell lysates,
Lane 3: monkey COS-7 whole cell lysates,
Lane 4: human HepG2 whole cell lysates,
Lane 5: human A549 whole cell lysates,
Lane 6: rat PC-12 whole cell lysates,
Lane 7: rat RH35 whole cell lysates,
Lane 8: mouse HEPA1-6 whole cell lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with mouse anti-Hsp90 alpha/HSP90AA1 antigen affinity purified monoclonal antibody (M01103-4) at a dilution of 1:1000 and probed with a goat anti-mouse IgG-HRP secondary antibody (Catalog # BA1050). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for Hsp90 alpha/HSP90AA1 at approximately 85-100 kDa. The expected band size for Hsp90 alpha/HSP90AA1 is at 85 kDa.
Figure 2. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human cervical cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 3. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human colon cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 4. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human lung cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 5. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human testis cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 6. IF analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in an immunocytochemical section of SiHa cells. The section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:100. Dylight488-conjugated Anti-mouse IgG Secondary Antibody (green)(Catalog#BA1126) was used as secondary antibody. The section was counterstained with DAPI (Catalog # AR1176) (Blue).
Figure 7. Flow Cytometry analysis of A549 cells using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Overlay histogram showing A549 cells stained with M01103-4 (Blue line). To facilitate intracellular staining, cells were fixed with 4% paraformaldehyde and permeabilized with permeabilization buffer. The cells were blocked with 10% normal goat serum. And then incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at 1:100 dilution for 30 min at 20°C. DyLight®488 conjugated goat anti-mouse IgG (BA1126) was used as secondary antibody at 1:100 dilution for 30 minutes at 20°C. Isotype control antibody (Green line) was mouse IgG at 1:100 dilution used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.
| Western blot (WB): | 1:500-2000 |
| Immunohistochemistry (IHC): | 1:50-400 |
| Immunocytochemistry/Immunofluorescence (ICC/IF): | 1:50-400 |
| Flow Cytometry (Fixed): | 1:50-200 |
| (Boiling the paraffin sections in 10mM citrate buffer,pH6.0,or PH8.0 EDTA repair liquid for 20 mins is required for the staining of formalin/paraffin sections.) Optimal working dilutions must be determined by end user. | |
Figure 1. Western blot analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human Hela whole cell lysates,
Lane 2: human HEK293 whole cell lysates,
Lane 3: monkey COS-7 whole cell lysates,
Lane 4: human HepG2 whole cell lysates,
Lane 5: human A549 whole cell lysates,
Lane 6: rat PC-12 whole cell lysates,
Lane 7: rat RH35 whole cell lysates,
Lane 8: mouse HEPA1-6 whole cell lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with mouse anti-Hsp90 alpha/HSP90AA1 antigen affinity purified monoclonal antibody (M01103-4) at a dilution of 1:1000 and probed with a goat anti-mouse IgG-HRP secondary antibody (Catalog # BA1050). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for Hsp90 alpha/HSP90AA1 at approximately 85-100 kDa. The expected band size for Hsp90 alpha/HSP90AA1 is at 85 kDa.
Figure 2. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human cervical cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 3. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human colon cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 4. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human lung cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 5. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human testis cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 6. IF analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in an immunocytochemical section of SiHa cells. The section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:100. Dylight488-conjugated Anti-mouse IgG Secondary Antibody (green)(Catalog#BA1126) was used as secondary antibody. The section was counterstained with DAPI (Catalog # AR1176) (Blue).
Figure 7. Flow Cytometry analysis of A549 cells using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Overlay histogram showing A549 cells stained with M01103-4 (Blue line). To facilitate intracellular staining, cells were fixed with 4% paraformaldehyde and permeabilized with permeabilization buffer. The cells were blocked with 10% normal goat serum. And then incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at 1:100 dilution for 30 min at 20°C. DyLight®488 conjugated goat anti-mouse IgG (BA1126) was used as secondary antibody at 1:100 dilution for 30 minutes at 20°C. Isotype control antibody (Green line) was mouse IgG at 1:100 dilution used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.
Figure 1. Western blot analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human Hela whole cell lysates,
Lane 2: human HEK293 whole cell lysates,
Lane 3: monkey COS-7 whole cell lysates,
Lane 4: human HepG2 whole cell lysates,
Lane 5: human A549 whole cell lysates,
Lane 6: rat PC-12 whole cell lysates,
Lane 7: rat RH35 whole cell lysates,
Lane 8: mouse HEPA1-6 whole cell lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with mouse anti-Hsp90 alpha/HSP90AA1 antigen affinity purified monoclonal antibody (M01103-4) at a dilution of 1:1000 and probed with a goat anti-mouse IgG-HRP secondary antibody (Catalog # BA1050). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for Hsp90 alpha/HSP90AA1 at approximately 85-100 kDa. The expected band size for Hsp90 alpha/HSP90AA1 is at 85 kDa.
Figure 2. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human cervical cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 3. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human colon cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 4. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human lung cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 5. IHC analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in a paraffin-embedded section of human testis cancer tissue. Biotinylated goat anti-mouse IgG was used as secondary antibody. The tissue section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1021) with DAB (Catalog # AR1022) as the chromogen.
Figure 6. IF analysis of Hsp90 alpha/HSP90AA1 using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Hsp90 alpha/HSP90AA1 was detected in an immunocytochemical section of SiHa cells. The section was incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at a dilution of 1:100. Dylight488-conjugated Anti-mouse IgG Secondary Antibody (green)(Catalog#BA1126) was used as secondary antibody. The section was counterstained with DAPI (Catalog # AR1176) (Blue).
Figure 7. Flow Cytometry analysis of A549 cells using anti-Hsp90 alpha/HSP90AA1 antibody (M01103-4).
Overlay histogram showing A549 cells stained with M01103-4 (Blue line). To facilitate intracellular staining, cells were fixed with 4% paraformaldehyde and permeabilized with permeabilization buffer. The cells were blocked with 10% normal goat serum. And then incubated with mouse anti-Hsp90 alpha/HSP90AA1 Antibody (M01103-4) at 1:100 dilution for 30 min at 20°C. DyLight®488 conjugated goat anti-mouse IgG (BA1126) was used as secondary antibody at 1:100 dilution for 30 minutes at 20°C. Isotype control antibody (Green line) was mouse IgG at 1:100 dilution used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.
联系我们027-67845390
关注我们
本司产品仅用于科研，不用于临床诊断和治疗
联系方式：027-67845390/1/2 技术支持：武汉丰网
© 1993-2025 Boster Biological Technology co.Itd E-mail:boster@boster.com
鄂ICP备05005548号-2
鄂公网安备 42018502007312号
积分商城 
购物车 
登录/注册 
您当前的位置： 
说明书
成功添加到购物车
微信客服
微信扫一扫立即咨询
